Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
27.54
-1.35 (-4.67%)
BSENSE

Nov 20

BSE+NSE Vol: 48.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
EQUITY AND LIABILITIES
No of Months
12
12
12
Share Capital
15.83
15.83
15.83
Share Warrants & Outstandings
Total Reserve
87.23
133.15
119.96
Shareholder's Funds
103.06
148.98
135.79
Minority Interest
0.00
0.00
0.00
Long-Term Borrowings
7.50
9.23
13.35
Secured Loans
3.63
8.70
12.44
Unsecured Loans
3.87
0.53
0.91
Deferred Tax Assets / Liabilities
5.20
9.82
12.09
Other Long Term Liabilities
2.63
6.8
8.41
Long Term Trade Payables
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Total Non-Current Liabilities
15.33
25.84
33.85
Current Liabilities
Trade Payables
75.91
98.17
66.16
Other Current Liabilities
24.74
21.37
22.31
Short Term Borrowings
94.56
70.96
74.60
Short Term Provisions
1.36
1.10
0.99
Total Current Liabilities
196.58
191.60
164.06
Total Liabilities
314.97
366.42
333.70
ASSETS
Non-Current Assets
0.00
0.00
0.00
Gross Block
283.85
269.95
232.39
Less: Accumulated Depreciation
139.07
122.08
107.42
Less : Impairment of Assets
0.00
0.00
0.00
Net Block
144.78
147.87
124.97
Lease Adjustment
0.00
0.00
0.00
Capital Work in Progress
0.00
1.38
0.00
Intangible assets under development
3.88
1.32
7.74
Pre-operative Expenses pending
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
Long Term Loans & Advances
0.28
1.99
2.29
Other Non Current Assets
0.00
0.00
0.00
Total Non-Current Assets
159.26
167.42
157.70
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
Inventories
102.77
138.80
123.64
Sundry Debtors
40.30
39.07
27.94
Cash and Bank
0.70
2.59
1.19
Other Current Assets
0.81
1.64
1.69
Short Term Loans and Advances
11.13
16.90
21.54
Total Current Assets
155.71
199.00
176.00
Net Current Assets (Including Current Investments)
-40.87
7.40
11.94
Total Current Assets Excluding Current Investments
155.71
199.00
176.00
Miscellaneous Expenses not written off
0.00
0.00
0.00
Total Assets
314.97
366.42
333.70
Contingent Liabilities
10.00
34.64
11.96
Total Debt
103.42
81.33
87.95
Book Value per share (adjusted)
0
89.65
85.79
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 27.27% vs -8.82% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -61.32% vs -19.14% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is -2.99% vs 19.43% in Mar 2025

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is -21.75% vs 13.07% in Mar 2025

Compare Balance Sheet Results of Mangalam Drugs
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
15.83
0
15.83
0.00%
Share Warrants & Outstandings
Total Reserve
87.23
0
87.23
0.00%
Shareholder's Funds
103.06
0
103.06
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
7.50
0
7.50
0.00%
Secured Loans
3.63
0
3.63
0.00%
Unsecured Loans
3.87
0
3.87
0.00%
Deferred Tax Assets / Liabilities
5.20
0
5.20
0.00%
Other Long Term Liabilities
2.63
0
2.63
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
15.33
0
15.33
0.00%
Current Liabilities
Trade Payables
75.91
0
75.91
0.00%
Other Current Liabilities
24.74
0
24.74
0.00%
Short Term Borrowings
94.56
0
94.56
0.00%
Short Term Provisions
1.36
0
1.36
0.00%
Total Current Liabilities
196.58
0
196.58
0.00%
Total Liabilities
314.97
0
314.97
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
283.85
0
283.85
0.00%
Less: Accumulated Depreciation
139.07
0
139.07
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
144.78
0
144.78
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
3.88
0
3.88
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
0.28
0
0.28
0.00%
Other Non Current Assets
0.00
0
0.00
0.00%
Total Non-Current Assets
159.26
0
159.26
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
102.77
0
102.77
0.00%
Sundry Debtors
40.30
0
40.30
0.00%
Cash and Bank
0.70
0
0.70
0.00%
Other Current Assets
0.81
0
0.81
0.00%
Short Term Loans and Advances
11.13
0
11.13
0.00%
Total Current Assets
155.71
0
155.71
0.00%
Net Current Assets (Including Current Investments)
-40.87
0
-40.87
0.00%
Total Current Assets Excluding Current Investments
155.71
0
155.71
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
314.97
0
314.97
0.00%
Contingent Liabilities
10.00
0
10.00
0.00%
Total Debt
103.42
0
103.42
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 102.06 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.27% vs -8.82% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 2.63 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -61.32% vs -19.14% in Mar 2025

Annual - Fixed Assets
Fixed Assets 144.78 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -2.99% vs 19.43% in Mar 2025

Annual - Investments
Investments 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 155.71 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -21.75% vs 13.07% in Mar 2025